Back to CL COOPERMAN LEON G

DMACDMAC
Showing 8 of 23 quarters

Position history for CLCOOPERMAN LEON G's holdings in DIAMEDICA THERAPEUTICS INC

COOPERMAN LEON G holds 3.5M shares of DMAC (DIAMEDICA THERAPEUTICS INC), worth $24.3M as of 2026-Q2. The position was increased (+70.8% shares). DMAC represents 0.7% of COOPERMAN LEON G's portfolio.

Current Value

$24.3M

Current Shares

3.5M

Total Value Change

+$18M

Total Shares Change

+1.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.5M
+70.8%
$24.3M0.7%$7.04
61
2026-Q1
Unchanged
2M
0.0%
$13.7M0.4%$7.71
0
2025-Q4
Decreased
2M
-38.2%
$16.1M0.5%$8.05
0
2025-Q3
Increased
3.3M
+98.2%
$17.6M0.6%$6.91
65
2025-Q2
Increased
1.7M
+1.5%
$6.4M0.2%$3.84
34
2025-Q1
Unchanged
1.6M
0.0%
$6.2M0.2%$3.82
0
2024-Q4
Increased
1.6M
+7.5%
$8.8M0.3%$5.34
36
2024-Q3
Increased
1.5M
+8.0%
$6.3M0.3%$4.18
36

Other major holders of DMAC: BlackRock, Inc., MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used